Rakovina Therapeutics (RKVTF) Q2 2026 Earnings

1JunConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.14
-0.11
-0.08
-0.06

Details

Expected EPS
N/A
Actual EPS
-0.0575136
Surprise EPS
-0.06
Surprise Percent
+∞%

Description

Rakovina Therapeutics (RKVTF) has reported earnings of -0.0575136 per share for Q2 2026.

0 Comments

Share your thoughts